Category: united states

Retraction appears for stem cell researcher found to have used funds for his company’s gain

Feuer_detail
Gerold Feuer in 2008, via Upstate

A stem cell journal is retracting a paper by Gerold Feuer, a researcher at the State University of New York (SUNY) Upstate Medical Center in Syracuse who was also found to have misused grants.

The Feuer story is complicated. Heralded in 2008 for landing $6.2 million in grants from the New York Stem Cell Board, Feuer was suspended in October 2010 while the university investigated allegations he had misused funds, specifically to funnel state dollars to HuMurine, a company he founded in 2008. In December 2010, Upstate said they had found evidence he had committed 53 acts of financial misconduct, and dismissed him.

From an August 2012 court ruling on a case Feuer brought to fight that dismissal: Continue reading Retraction appears for stem cell researcher found to have used funds for his company’s gain

Cancer cell line mixup leads to retraction

ccr 9-15At team of researchers at MD Anderson Cancer Center has retracted a paper after realizing that the cell lines they were using weren’t what they thought they were.

Here’s the detailed notice: Continue reading Cancer cell line mixup leads to retraction

Spat over tuberculosis study data leads to Expression of Concern

jcmA fight over who owns tuberculosis study data has led the Journal of Clinical Microbiology to publish an Expression of Concern.

Here’s the notice: Continue reading Spat over tuberculosis study data leads to Expression of Concern

Journal retracts two chemistry papers for plagiarism

commnonlinscinumsimCommunications in Nonlinear Science and Numerical Simulation has retracted a pair of articles by a group of chemists from Iran and the United States after finding evidence of plagiarism in the papers.

The researcher team included authors from Islamic Azad University, Ferdowski University of Mashhad and, perhaps somewhat incongruously, Ball State University in Muncie, Indiana.

The first paper, “An analytical approach to the stability of solitary solutions of cubic–quintic coupled non-linear Schrödinger equations,” appeared in 2009 and has been cited twice, according to Thomson Scientific’s Web of Knowledge. (Question: is an article that will ultimately be retracted for plagiarism considered to exist in a state of un-retracted retractionness, such that by detecting the plagiarized text the article immediately ceases to be?):

Continue reading Journal retracts two chemistry papers for plagiarism

Fredrickson-Losada “positivity ratio” paper partially withdrawn

am psychIn 2005, Barbara Fredrickson and Marcial Losada published a paper in American Psychologist making a bold and specific claim:

…the authors predict that a ratio of positive to negative affect at or above 2.9 will characterize individuals in flourishing mental health.

The paper made quite a splash. It has been cited 360 times, according to Thomson Scientific’s Web of Knowledge, and formed the basis of a 2009 book by Fredrickson, Positivity: Top-Notch Research Reveals the 3 to 1 Ratio That Will Change Your Life.

But something didn’t sit right with Nick Brown, a psychology grad student at the University of East London. He found the paper’s claims wanting, and contacted Alan Sokal — yes, that Alan Sokal, who published a fake paper in Social Text in 1996. Sokal agreed, and he, Brown, and Harris Friedman published a critique of the paper in July of this year in American Psychologist. Its abstract: Continue reading Fredrickson-Losada “positivity ratio” paper partially withdrawn

What happens to postdocs sanctioned by the ORI?

AJOB primaryIn a finding that’s unlikely to surprise too many people, but which is interesting work nonetheless, researchers have found that trainees whom the U.S. Office of Research Integrity finds to have committed misconduct rarely publish much again. According to the paper, only 11% of trainees who committed misconduct published more than one article a year.

That’s not quite the case for more seasoned scientists who show up in ORI reports, as the researchers — Barbara Redman and Jon Merz — had discovered in previous work. Here’s the abstract of the new paper, “Effects of Findings of Scientific Misconduct on Postdoctoral Trainees,” which appeared in August in the American Journal of Bioethics — Primary Research (not the AJOB, as we’d first reported): Continue reading What happens to postdocs sanctioned by the ORI?

It’s an epidemic! Another group does the right thing, retracting neuroscience paper

jneurosciAs the bumper sticker says, “Regime change starts at home.” Seems to be the case with scientists these days.

This month we have seen commendable instances of researchers retracting papers after identifying flaws in their own data — an outbreak of integrity that has us here at Retraction Watch applauding. (We’ve even created a new category, “doing the right thing,” at the suggestion of a reader.)

Today’s feel-good story comes from the lab of Karl Svoboda, of the Howard Hughes Medical Institute’s Janelia Farm Research Campus, in Ashburn, Va. Back in June, Svoboda and his colleagues published “Whisker Dynamics Underlying Tactile Exploration,” in the Journal of Neuroscience. Here’s what the abstract had to say about the study:

Continue reading It’s an epidemic! Another group does the right thing, retracting neuroscience paper

A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

cancer cell 9-13MIT’s Robert Weinberg, a leading cancer researcher who retracted a Cancer Cell paper earlier this year for “inappropriate presentation” of figures, has corrected a different paper in the same journal.

Here’s the correction for “Species- and Cell Type-Specific Requirements for Cellular Transformation:”

We were apprised recently of errors made in the assembly of Figures 2B, 3A, 4A, 4B, and 5G, resulting in the incorporation of incorrect representative images in these figures. These errors occurred during the electronic assembly and have no bearing on the conclusions of the study. The corrected figures are shown below. The authors apologize for any possible confusion this might have caused.

Here’s the original Figure 2 and caption, followed by the new version (read all the way to the end of the post for more details on how this came to light): Continue reading A Cancer Cell mega-correction for highly cited researcher who retracted paper earlier this year

Doing the right thing: Researchers retract quorum sensing paper after public process

Pamela Ronald, via UC Davis
Pamela Ronald, via UC Davis

We’ll say it again: We like being able to point out when researchers stand up and do the right thing, even at personal cost.

In December 2011, Pamela C. Ronald, of the University of California, Davis, and colleagues published a paper in PLOS ONE,”Small Protein-Mediated Quorum Sensing in a Gram-Negative Bacterium.” Such quorum sensing research is a “hot topic” right now, so not surprisingly the paper caught the attention of other scientists, and the media, including the Western Farm Press. The study has been cited eight times, according to Thomson Scientific’s Web of Knowledge.

One of those scientists who took notice was Ronald’s UC Davis colleague Jonathan Eisen, who posted about the paper on his blog. That was on January 9, 2012. But if you go to that post today, you’ll see that Eisen struck through most of it, and added this comment: Continue reading Doing the right thing: Researchers retract quorum sensing paper after public process

Papers on potential cancer drugs retracted for image manipulation

ccr 9-13A group of researchers at the Einstein College of Medicine in the Bronx, New York has retracted two papers for image manipulation.

The retraction notices for “PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase” and “The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab” say the same thing: Continue reading Papers on potential cancer drugs retracted for image manipulation